Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia

被引:60
作者
Wright, TW
Notter, RH
Wang, ZD
Harmsen, AG
Gigliotti, F
机构
[1] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA
[2] Trudeau Inst Inc, Saranac Lake, NY 12983 USA
关键词
D O I
10.1128/IAI.69.2.758-764.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During Pneumocystis carinii pneumonia (PCP) in mice, the degree of pulmonary inflammation correlates directly with the severity of lung function deficits. Therefore, studies were undertaken to determine whether the host inflammatory response contributes to PCP-related respiratory impairment, at least in part, by disrupting the pulmonary surfactant system, Protein and phospholipid content and surfactant activity were measured in the lavage fluid of infected mice in either the absence or presence of an inflammatory response, At 9 weeks postinfection with P. carinii, nonreconstituted SCID mice exhibited no signs of pulmonary inflammation, respiratory impairment, or surfactant dysfunction, Lavage fluid obtained from these mice had protein/phospholipid (Pr/PL) ratios (64% +/- 4.7%) and minimum surface tension values (4.0 +/- 0.9 mN/m) similar to those of P. carinii-free control mice. However, when infected SCID mice were immunologically reconstituted, an intense inflammatory response ensued, Pr/PL ratios (218% +/- 42%) and minimum surface tension values (27.2 +/- 2.7 mN/m) of the lavage fluid were significantly elevated compared to those of the lavage fluid from infected, nonreconstituted mice (P < 0.05). To examine the specific role of CD8(+) T-cell-mediated inflammation in surfactant dysfunction during PCP, mice with defined T-cell populations were studied. P. carinii-infected, CD4(+)-depleted mice had elevated lavage fluid Pr/PL ratios (126% +/- 20%) and elevated minimum surface tension values (16.3 +/- 1.0 mN/m) compared to normal mice (P < 0.05). However, when infected mire were additionally depleted of CD8(+) cells, Pr/PL ratios were normal and surfactant activity was improved, These findings demonstrate that the surfactant pathology associated with PCP is related to the inflammatory process rather than being a direct effect of P. carinii. Moreover, CD8(+) lymphocytes are involved in the mechanism leading to surfactant dysfunction.
引用
收藏
页码:758 / 764
页数:7
相关论文
共 60 条
[1]  
Ames B., 1966, METHOD ENZYMOL, V8, P115, DOI DOI 10.1016/0076-6879(66)08014-5
[2]   TUMOR NECROSIS FACTOR-ALPHA-INDUCED INHIBITION OF PHOSPHATIDYLCHOLINE SYNTHESIS BY HUMAN TYPE-II PNEUMOCYTES IS PARTIALLY MEDIATED BY PROSTAGLANDINS [J].
ARIASDIAZ, J ;
VARA, E ;
GARCIA, C ;
BALIBREA, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :244-250
[3]   P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant [J].
Atochina, EN ;
Beers, MF ;
Scanlon, ST ;
Preston, AM ;
Beck, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 278 (03) :L599-L609
[4]   Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice [J].
Beers, MF ;
Atochina, EN ;
Preston, AM ;
Beck, JM .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 133 (05) :423-433
[5]   Surfactant associated protein-a inhibits human lymphocyte proliferation and IL-2 production [J].
Borron, P ;
Veldhuizen, RAW ;
Lewis, JE ;
Possmayer, F ;
Caveney, A ;
Inchley, K ;
McFadden, RG ;
Fraher, LJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1996, 15 (01) :115-121
[6]  
Creery WD, 1997, PEDIATR PULM, V24, P370, DOI 10.1002/(SICI)1099-0496(199711)24:5<370::AID-PPUL10>3.0.CO
[7]  
2-6
[8]   EFFECT OF SURFACTANT REPLACEMENT ON PNEUMOCYSTIS-CARINII PNEUMONIA IN RATS [J].
EIJKING, EP ;
VANDAAL, GJ ;
TENBRINCK, R ;
LUIJENDIJK, A ;
SLUITERS, JF ;
HANNAPPEL, E ;
LACHMANN, B .
INTENSIVE CARE MEDICINE, 1991, 17 (08) :475-478
[9]   PULSATING BUBBLE TECHNIQUE FOR EVALUATING PULMONARY SURFACTANT [J].
ENHORNING, G .
JOURNAL OF APPLIED PHYSIOLOGY, 1977, 43 (02) :198-203
[10]   SURFACTANT ANALYSIS DURING PNEUMOCYSTIS-CARINII PNEUMONIA IN HIV-INFECTED PATIENTS [J].
ESCAMILLA, R ;
PREVOST, MC ;
HERMANT, C ;
CARATERO, A ;
CARIVEN, C ;
KREMPF, M .
CHEST, 1992, 101 (06) :1558-1562